Investors pulled $1.2 billion out of health care and biotech funds last week — the largest weekly outflow of money from the sector since February 2016, according to a new analysis.
The acceleration of investor money leaving biotech funds is reflected in plunging stock prices. The Nasdaq Biotech Index fell 4 percent in the five trading days ended on Feb. 7, the time period matching the $1.2 billion outflow. (Fund flows are reported on a Wednesday-to-Wednesday weekly schedule.)
About the Author Reprints
I appreciate the knowledge that you have in the healthcare and biotech space.
I enjoyed reading your articles. Very informative.